Tigecycline resistance in clinical isolates ofEnterococcus faeciumis mediated by an upregulation of plasmid-encoded tetracycline determinantstet(L) andtet(M)
Author(s) -
S. Fiedler,
Jennifer K. Bender,
Ingo Klare,
Sven Halbedel,
Elisabeth Grohmann,
Ulrich Szewzyk,
Guido Werner
Publication year - 2015
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkv420
Subject(s) - tigecycline , enterococcus faecium , microbiology and biotechnology , tetracycline , plasmid , biology , enterococcus , antibiotics , medicine , dna , genetics
Tigecycline represents one of the last-line therapeutics to combat multidrug-resistant bacterial pathogens, including VRE and MRSA. The German National Reference Centre for Staphylococci and Enterococci has received 73 tigecycline-resistant Enterococcus faecium and Enterococcus faecalis isolates in recent years. The precise mechanism of how enterococci become resistant to tigecycline remains undetermined. This study documents an analysis of the role of efflux pumps in tigecycline resistance in clinical isolates of Enterococcus spp.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom